NCT00005830
- Conditions
- Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, +2 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Clinical trial condition
Stage III Uterine Corpus Cancer
Explore clinical trials studying Stage III Uterine Corpus Cancer. Study availability and eligibility vary by location and protocol.
12 public trials
0 recruiting studies
Stage III Uterine Corpus Cancer trial results
NCT00005840
- Conditions
- Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer, +1 more
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
Related conditions
- Stage IV Uterine Corpus Cancer (10)
- Stage I Uterine Corpus Cancer (7)
- Stage II Uterine Corpus Cancer (7)
- Recurrent Uterine Corpus Carcinoma (5)
- Endometrial Adenocarcinoma (4)
- Endometrial Serous Adenocarcinoma (4)
- Female Urogenital Diseases (4)
- Female Urogenital Diseases and Pregnancy Complications (4)